Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kestrel Merchant Partners is an investment and advisory firm specializing in strategic advisory, public equity investments (via Kestrel Flight Fund and Kestrel Phoenix Fund focusing on small cap special situations, turnarounds, and broken SPACs), private equity in the lower middle market, and venture capital for early-stage companies. The firm merged with Asydan Capital Management and now operates as Caydan Capital Partners, concentrating on business services, healthcare, technology, and consumer products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kestrel Merchant Partners.